CVS Health Furnishes Board Changes
Summary
CVS Health Corporation announced board changes, with Larry M. Robbins resigning from the Board on August 13, 2026, effective immediately. His departure was not the result of any disagreement with the Company. On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026, as disclosed via Ex. 99.1 press release. Ms. Heitsenrether brings nearly forty years of financial services leadership experience, currently serving as Chief Data & Analytics Officer at JPMorgan Chase & Co.
Why It Matters
The appointment of Teresa Heitsenrether, with her extensive experience in data, analytics, and technology from a major financial institution, is significant as CVS Health aims to become a consumer-focused health technology company. Her deep knowledge is expected to be invaluable for driving technology-enabled transformation, as stated in the Ex. 99.1 press release.
These filing summaries are free and always will be. If this helped you spot material events, consider supporting us.
Want to see how CVS traded around this filing?
Check real-time charts and technical analysis on TradingView to see market reaction to this event.
View CVS Charts on TradingViewAffiliate link
Is this filing part of a pattern?
One disclosure is noise. Get a structured briefing covering 12 months of SEC filings, disclosure signals, and what to watch next.
Key Quote
“On August 17, 2026, the Board appointed Teresa Heitsenrether to the Board, effective November 18, 2026.”
— From Item 5.02
Filing Details
Reported Items
Additional Information
- CIK Number
- 0000064803
- Filing Date
- Monday, August 17, 2026
- Filing Time
- 12:00 AM UTC
- Form Type
- 8-K
- Materiality Level
- high
- Sentiment
- neutral